Results 181 to 190 of about 130,158 (334)

Regulation of Cytoplasmic pH in Osteoclasts [PDF]

, 1995
Tommy Nordström, Ori D. Rotstein, R Romanek, Satish Asotra, Johannes N.M. Heersche, Morris F. Manolson, Guy F. Brisseau, Sergio Grinstein   +7 more
openalex   +1 more source

Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Rheumatoid arthritis (RA)–associated anticitrullinated protein antibodies (ACPAs) target various antigens by binding short citrulline amino acid motifs, resulting in heterogeneous ACPA profiles among patients. Here we analyzed ACPA patterns by recognized citrulline motifs in relation to the RA risk factors HLA‐DRB1 shared epitope (SE) alleles
Linda Mathsson Alm, Helga Westerlind, Isabel Gehring, Monika Hansson, Nasim Ghasemzadeh, Jessica Rojas‐Restrepo, Saedis Saevarsdottir, Joe Sexton, Siri Lillegraven, Espen Haavardsholm, Bente Glintborg, Hilde Berner Hammer, Tore K. Kvien, Merete Lund Hetland, Leonid Padyukov, Swedish Rheumatology Quality Register Biobank Study Group (SRQb), The Danish Rheumatologic Biobank Study Group, Johan Askling, Caroline Grönwall   +18 more
wiley   +1 more source

Licochalcone D inhibits osteoclast differentiation and postmenopausal osteoporosis by inactivating the NF-κB signaling pathway. [PDF]

J Orthop Surg Res
Shen X, Zhang Q, Ding J, Zhou J, Tan S, Feng X, Xu Z, Hua F.   +7 more
europepmc   +1 more source

Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA. [PDF]

, 1995
J.R. Connor, Robert A. Dodds, Ian E. James, Maxine Gowen   +3 more
openalex   +1 more source

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

Arthritis &Rheumatology, EarlyView.
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley   +1 more source

Cathepsin B and L activities in isolated osteoclasts

, 1991
Barry R. Rifkin, Anthony Vernillo, Audrey P. Kleckner, Jeanine M. Auszmann, L R Rosenberg, Morris Zimmerman   +5 more
openalex   +1 more source

Initiation of Osteoclast Bone Resorption by Interstitial Collagenase [PDF]

, 1997
L. Shannon Holliday, Howard G. Welgus, Catherine J. Fliszar, G. Michael Veith, John J. Jeffrey, Stephen L. Gluck   +5 more
openalex   +1 more source

Deciphering the skeletal interoceptive circuitry to control bone homeostasis

BMEMat, EarlyView.
This review introduces the skeletal interoceptive circuitry, covering the ascending signals from bone tissues to the brain (sensors), the central neural circuits that integrate this information and dispatch commands (CPU), and the descending pathways that regulate bone homeostasis (effectors).
Yefeng Wu, Jiusi Guo, Zhen Chen, Fengwei Zhang, Billy Kwok Chong Chow, Zhuofan Chen, Kelvin Wai‐Kwok Yeung, Wei Qiao   +7 more
wiley   +1 more source

Female Mice Lacking LSD1 in Myeloid Cells Are Resistant to Inflammatory Bone Loss. [PDF]

Cells
Astleford-Hopper K, Saavedra F, Bittner-Eddy P, Stein C, Auger J, Clark R, Abrahante Llorens JE, Binstadt BA, Thumbigere-Math V, Mansky KC.   +9 more
europepmc   +1 more source

Inhibitory Effects of the Bone-Derived Growth Factors Osteoinductive Factor and Transforming Growth Factor-β on Isolated Osteoclasts*

, 1990
Richard O. C. Oreffo, Lynda F. Bonewald, Akiko Kukita, I. Ross Garrett, Saeid M. Seyedin, David W. Rosen, Gregory R. Mundy   +6 more
openalex   +1 more source